Crossmark

The combined use of HA380 hemoperfusion in cardiopulmonary bypass alleviates postoperative inflammatory response and organ dysfunction following cardiac surgery

Crossref DOI link: https://doi.org/10.1186/s13019-026-03955-8

Published Online: 2026-04-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Longlong

Li, Jing

Li, Hui

Wang, Suli

Chen, Chunyu

Zhang, Biao
License Information

Text and Data Mining valid from 2026-04-03

Version of Record valid from 2026-05-14
More Information

Article History

Received: 11 August 2025

Accepted: 25 March 2026

First Online: 3 April 2026

Declarations

:

: The study protocol was approved by ethics committee of Fuyang Hospital Affiliated to Anhui Medical University (Number of IRB approval: KY2022140, Date of IRB approval: Aug 26th, 2022). All enrolled patients provided written informed consent to participate in this study. The patients/participants also gave written informed consent to publish identifying details such as their age, gender, and illness. The study comply with the guidelines for human studies and the research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below